Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Contract

24 Sep 2019 07:00

RNS Number : 3679N
Galliford Try PLC
24 September 2019
 

GALLIFORD TRY APPOINTED TO HIGHWAYS PROJECTS VALUED AT £461M

 

Galliford Try plc, the leading housebuilding, regeneration and construction group, announces its Highways business has been appointed to new projects valued at a total of £461m.

 

The largest of the schemes is a series of five projects in the eastern region valued at £300m to upgrade the A47 between Great Yarmouth and Peterborough. Work includes dualling single carriageways, road widening and construction of new junctions, bridges and other structures. Start on site is anticipated to be in 2021/22.

 

The other major scheme with an overall value of £135m is located in the south-west region on the A303 between Sparkford and Ilchester in Somerset. Work includes dualling 5.6km of the existing single carriageway, three new junctions, two new structures and significant earthworks. Subject to planning consent, start on site is due next March with the new route open to traffic in 2023.

 

Both schemes have been awarded by Highways England under the new Regional Delivery Partnerships Framework. The appointments include an initial design phase before moving on to construction.

 

Additionally, Galliford Try has been awarded phase two of Grantham Southern Relief Road by Lincolnshire County Council. The £19m project will join the B1174 to the A1 via a grade separated junction.

 

Finally, Leicestershire County Council has awarded the business the £7m contract to carry out improvements to the A46 and A5630 at Anstey to increase capacity for a new housing and industrial development in the north-west of Leicester.

 

Graham Prothero, Chief Executive of Galliford Try plc, commented: "The Highways sector is a key strategic focus for our construction business as set out in our recent results, and we are delighted to have secured this high-quality pipeline of work. We have a strong working relationship with Highways England and the county councils involved and we look forward to delivering these much-needed infrastructure improvements alongside them."

 

 

For further enquiries please contact:

 

Galliford Try

 

Graham Prothero, Chief Executive 01895 855001

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel & Company Secretary

 

Galliford Try plc is a leading UK housebuilding, regeneration and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2019, the Group generated revenue of £2.8bn.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTDXLFLKKFFBBZ
Date   Source Headline
21st May 20197:00 amRNSTrading Statement
1st May 201912:00 pmRNSTotal Voting Rights
25th Apr 20197:00 amRNSContract
18th Apr 20192:55 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSOperational Update
8th Apr 201911:52 amRNSHolding(s) in Company
2nd Apr 20197:00 amRNSContract
26th Mar 20197:00 amRNSDirectorate Change
18th Mar 20192:46 pmRNSHolding(s) in Company
14th Mar 20193:24 pmRNSHolding(s) in Company
7th Mar 20193:33 pmRNSHolding(s) in Company
7th Mar 201910:00 amRNSHolding(s) in Company
28th Feb 20194:39 pmRNSHolding(s) in Company
28th Feb 20192:48 pmRNSHolding(s) in Company
19th Feb 20191:21 pmRNSHolding(s) in Company
19th Feb 20199:00 amRNSHolding(s) in Company
19th Feb 20199:00 amRNSHolding(s) in Company
18th Feb 20197:00 amRNSAWPR Handover and Major Ealing Regeneration Scheme
15th Feb 20199:00 amRNSHolding(s) in Company
13th Feb 20197:00 amRNSHalf-year Report
8th Feb 20192:26 pmRNSHolding(s) in Company
28th Dec 20181:31 pmRNSHolding(s) in Company
21st Dec 20188:00 amRNSHolding(s) in Company
18th Dec 20183:00 pmRNSDirector/PDMR Shareholding
11th Dec 201812:00 pmRNSDirector/PDMR Shareholding
3rd Dec 201812:00 pmRNSTotal Voting Rights
27th Nov 201810:00 amRNSBlock listing Interim Review
23rd Nov 20184:39 pmRNSHolding(s) in Company
22nd Nov 20184:48 pmRNSHolding(s) in Company
9th Nov 20183:14 pmRNSResult of AGM
9th Nov 20187:00 amRNSAGM Statement
7th Nov 20181:05 pmRNSContract
7th Nov 20181:00 pmRNSTrading Statement
25th Oct 20183:12 pmRNSHolding(s) in Company
24th Oct 20183:00 pmRNSDirector/PDMR Shareholding
18th Oct 20181:00 pmRNSHolding(s) in Company
16th Oct 20181:00 pmRNSHolding(s) in Company
11th Oct 20187:00 amRNSCapital Markets Day
8th Oct 201812:30 pmRNSHolding(s) in Company
1st Oct 20184:00 pmRNSTotal Voting Rights
1st Oct 20182:00 pmRNSHolding(s) in Company
28th Sep 20183:00 pmRNSAnnual Financial Report
27th Sep 20184:00 pmRNSDirector/PDMR Shareholding
27th Sep 20184:00 pmRNSDirector/PDMR Shareholding
24th Sep 20186:00 pmRNSHolding(s) in Company
21st Sep 20184:00 pmRNSHolding(s) in Company
21st Sep 20183:18 pmRNSDirector/PDMR Shareholding
21st Sep 20183:11 pmRNSDirector/PDMR Shareholding
18th Sep 20183:30 pmRNSHolding(s) in Company
17th Sep 20183:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.